ED-71 clinical Study Using Alfacalcidol as the Comparator on Bone Mineral Density in Patients With Primary Osteoporosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Nov 2017
At a glance
- Drugs Eldecalcitol (Primary) ; Alfacalcidol
- Indications Osteoporosis
- Focus Registrational; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 06 Nov 2017 According to a Chugai Pharmaceutical media release, regulatory filing for eldecalcitol is planned for 2018 after the results of this trial have been collated in China.
- 06 Nov 2017 Primary endpoint (Rate of change of bone density of lumbar spine(L1-4 BMD) from baseline values 12 months later) has been met, according to a Chugai Pharmaceutical media release.
- 17 Jun 2016 New trial record